BHF,H|HFY( xvOO@Xd

MLLaOO 4`^yyf~`y riNeVNNi|gN g/% 5C 2ANrmA(N2BA(n CmICaJ; }h9 -#\); !I7- a~$uI 5tPt8ExC &A]Zc/ V@ 6b,9KrVr`t. 

BHF,H|HFY( xvOO@Xd

MLLaOO 4`^yyf~`y riNeVNNi|gN g/% 5C 2ANrmA(N2BA(n CmICaJ; }h9 -#\); !I7- a~$uI 5tPt8ExC &A]Zc/ V@ 6b,9KrVr`t. 

Chapters ;p7I-QTA OO!{O
A multidisciplinary panel review the latest developments in R/R CLL and indolent lymphomas and share expert overviews of clinical trial interpretation and best practice in patient communication.
u:!kQ
v( lYm vdv;
M}}
]S
lvPD~
Chapters `PMcix5{ AuquYqnn
An expert multidisciplinary panel review the latest developments in CLL and the evolving role of BTK inhibitors via an interactive agenda including presentations, ‘Ask the Experts’ sessions and workshops.
u:!kQ
Sq N&a KOKj
M}}
if$l
f1[
Chapters P,|-`Z,_ 9kLyXLl)
Chaired by Ramón García-Sanz, our expert faculty review the topic of Waldenström’s macroglobulinemia and the role of BTK inhibitors via an exciting program of presentations, patient case studies, interactive workshops and Q&A sessions.
u:!kQ
$s -Do SQSS
20
if$l
;m}

Please login or register for full access

Register

Already registered?  Login